MRF-Logo2019-Horizontal-RGB
Help getting access to lambrolizumab
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Help getting access to lambrolizumab

› Forums › General Melanoma Community › Help getting access to lambrolizumab

  • Post
    • July 30, 2014 at 7:44 pm
    Damien83
    Participant

      Hello,

       

      I'm not oncologist, just a GP and I wish I can help one of my patient and friend here in Europe to access this treatment (or the other anti-PD-1 antibody) …

      Is there a way to get it under "compationate use" she will pay for it , is she can afford…

      Looking for any assistance in this way,

       

      thank you for this usefull board

    Viewing 14 reply threads
    • Replies
        • July 30, 2014 at 7:54 pm
        Julie in SoCal
        Participant

          Sorry I can't answer you question, but you might want to also check with Catherine Poole at MIF (http://forum.melanomainternational.org/mif/).  That board tends to have a bit more of an international scope.

          Shalom,

          Julie

          • July 30, 2014 at 7:54 pm
          Julie in SoCal
          Participant

            Sorry I can't answer you question, but you might want to also check with Catherine Poole at MIF (http://forum.melanomainternational.org/mif/).  That board tends to have a bit more of an international scope.

            Shalom,

            Julie

            • July 30, 2014 at 7:54 pm
            Julie in SoCal
            Participant

              Sorry I can't answer you question, but you might want to also check with Catherine Poole at MIF (http://forum.melanomainternational.org/mif/).  That board tends to have a bit more of an international scope.

              Shalom,

              Julie

              • July 30, 2014 at 9:01 pm
              jualonso
              Participant

                In Spain is possible to get it under compassionate use, after ipi fail or braf inh.

                Where are you from?

                • July 30, 2014 at 9:01 pm
                jualonso
                Participant

                  In Spain is possible to get it under compassionate use, after ipi fail or braf inh.

                  Where are you from?

                  • July 30, 2014 at 9:01 pm
                  jualonso
                  Participant

                    In Spain is possible to get it under compassionate use, after ipi fail or braf inh.

                    Where are you from?

                    • July 30, 2014 at 9:07 pm
                    ed williams
                    Participant

                      Take a look at the post from Tim of the MRA dated 7/10 /2014. He talks about the expanded access to the Ipilimumab and Nivolumab combination by Bristol Myer Squibb. Also the name has changed from MK-3475 to Lambrolizumab to Pembrolizumab. Dr. Antoni Ribas at UCLA is involved with the research on this drug but I am not sure where or how you would get access. I know that Nivolumab has become available in Japan by Ono Pharmaceutical Co, where they call it Opdivo. Hope this helps!!! Ed

                      • July 30, 2014 at 9:07 pm
                      ed williams
                      Participant

                        Take a look at the post from Tim of the MRA dated 7/10 /2014. He talks about the expanded access to the Ipilimumab and Nivolumab combination by Bristol Myer Squibb. Also the name has changed from MK-3475 to Lambrolizumab to Pembrolizumab. Dr. Antoni Ribas at UCLA is involved with the research on this drug but I am not sure where or how you would get access. I know that Nivolumab has become available in Japan by Ono Pharmaceutical Co, where they call it Opdivo. Hope this helps!!! Ed

                        • July 30, 2014 at 9:07 pm
                        ed williams
                        Participant

                          Take a look at the post from Tim of the MRA dated 7/10 /2014. He talks about the expanded access to the Ipilimumab and Nivolumab combination by Bristol Myer Squibb. Also the name has changed from MK-3475 to Lambrolizumab to Pembrolizumab. Dr. Antoni Ribas at UCLA is involved with the research on this drug but I am not sure where or how you would get access. I know that Nivolumab has become available in Japan by Ono Pharmaceutical Co, where they call it Opdivo. Hope this helps!!! Ed

                            • July 30, 2014 at 9:45 pm
                            Damien83
                            Participant

                              thank you very much all three, I didn't expect so quick response!

                              I'm in france and indeed my prescription as GP may not be enough to convince a lab in my opinion ..

                              That's also often I have patients with NSCLC and I'm in the same situation, I see some additional possibilities abroad and can't access them 

                              here no oncologist will take the responsability to prescribe a drug that has not approbation in the country … they are so afraid to get troubles

                              If anyone has a more precise suggestion it create en temporary email to take contact no to leave my identity on this board … 

                              feel free to leave a message at [email protected] , sorry not to give my true email , I don't want to lose my med board registration…

                              • July 30, 2014 at 9:45 pm
                              Damien83
                              Participant

                                thank you very much all three, I didn't expect so quick response!

                                I'm in france and indeed my prescription as GP may not be enough to convince a lab in my opinion ..

                                That's also often I have patients with NSCLC and I'm in the same situation, I see some additional possibilities abroad and can't access them 

                                here no oncologist will take the responsability to prescribe a drug that has not approbation in the country … they are so afraid to get troubles

                                If anyone has a more precise suggestion it create en temporary email to take contact no to leave my identity on this board … 

                                feel free to leave a message at [email protected] , sorry not to give my true email , I don't want to lose my med board registration…

                                • July 30, 2014 at 9:45 pm
                                Damien83
                                Participant

                                  thank you very much all three, I didn't expect so quick response!

                                  I'm in france and indeed my prescription as GP may not be enough to convince a lab in my opinion ..

                                  That's also often I have patients with NSCLC and I'm in the same situation, I see some additional possibilities abroad and can't access them 

                                  here no oncologist will take the responsability to prescribe a drug that has not approbation in the country … they are so afraid to get troubles

                                  If anyone has a more precise suggestion it create en temporary email to take contact no to leave my identity on this board … 

                                  feel free to leave a message at [email protected] , sorry not to give my true email , I don't want to lose my med board registration…

                                • July 31, 2014 at 4:52 pm
                                tcell
                                Participant
                                  Hello,
                                   
                                  I think you need to transfer your patient to Villejuif to the Institut  Gustave Roussy. they are as far as I know the only French site where the Merck EAP for Pembrolizumab is open. So they will get access for your friend.
                                   
                                  If he / she is BRAF+ he has to have failed this and he has to habe failed Ipilimumab. There are some more criteria that the people at the IGR wil know.
                                   
                                  hope this helps!
                                  • July 31, 2014 at 4:52 pm
                                  tcell
                                  Participant
                                    Hello,
                                     
                                    I think you need to transfer your patient to Villejuif to the Institut  Gustave Roussy. they are as far as I know the only French site where the Merck EAP for Pembrolizumab is open. So they will get access for your friend.
                                     
                                    If he / she is BRAF+ he has to have failed this and he has to habe failed Ipilimumab. There are some more criteria that the people at the IGR wil know.
                                     
                                    hope this helps!
                                    • July 31, 2014 at 4:52 pm
                                    tcell
                                    Participant
                                      Hello,
                                       
                                      I think you need to transfer your patient to Villejuif to the Institut  Gustave Roussy. they are as far as I know the only French site where the Merck EAP for Pembrolizumab is open. So they will get access for your friend.
                                       
                                      If he / she is BRAF+ he has to have failed this and he has to habe failed Ipilimumab. There are some more criteria that the people at the IGR wil know.
                                       
                                      hope this helps!
                                      • July 31, 2014 at 5:48 pm
                                      LuckyMan51
                                      Participant

                                        Anti-pd1 therapies have been recently approved in Japan. Perhaps your friend can get a referral to a Japanese Melanoma  Oncologist there who can prescribe treatment and pay out of pocket.  Worth a look.   

                                        • July 31, 2014 at 5:48 pm
                                        LuckyMan51
                                        Participant

                                          Anti-pd1 therapies have been recently approved in Japan. Perhaps your friend can get a referral to a Japanese Melanoma  Oncologist there who can prescribe treatment and pay out of pocket.  Worth a look.   

                                          • July 31, 2014 at 5:48 pm
                                          LuckyMan51
                                          Participant

                                            Anti-pd1 therapies have been recently approved in Japan. Perhaps your friend can get a referral to a Japanese Melanoma  Oncologist there who can prescribe treatment and pay out of pocket.  Worth a look.   

                                        Viewing 14 reply threads
                                        • You must be logged in to reply to this topic.
                                        About the MRF Patient Forum

                                        The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                                        The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                                        Popular Topics